,,hummmmm,,,,,,,did DM not tell us that patients in this trial asked to remain on 208 even after their dosing time was met,,,,,,,,,,,,,,,,,,,can we read anything into this??....should we?......my take is that they experienced a noticable increase in overall better health due primarily to a reduction of inflammation throughout the body,,,,it is possible imo,,,,,,,,,,,kidneys working better,,,,,,increase flow in older patients,,mind sharper maybe,,,,sight better,,,,,,I dont understand why any individual would have requested an extension in such a trial unless something physical improved for the person,,,,and we were also told everyone wanted to stay on it!..... or then again..possibly the data data data will provide us with new focus,,!!